» Articles » PMID: 29391809

High-frequency Deregulated Expression of Wnt Signaling Pathway Members in Breast Carcinomas

Overview
Publisher Dove Medical Press
Specialty Oncology
Date 2018 Feb 3
PMID 29391809
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Breast carcinoma is the most common malignancy and leading cause of cancer-related deaths in women worldwide including Saudi Arabia. Breast cancer in Saudi women develops at a much early age with median age of onset of 49 years compared to 62 years observed in patients from USA. Aberrations in wingless and integration site growth factor (Wnt) signaling pathway have been pathologically implicated in development of breast cancers and hence its role was examined in Saudi patients.

Materials And Methods: We immunohistochemically examined various components of Wnt signaling pathway including β-catenin, tumor suppressor proteins, adenomatous polyposis coli (APC), and Axin, expression of naturally occurring pathway antagonists such as Dickkopf Wnt signaling pathway inhibitor 3 (DKK3), FRP2, and WIF1, as well as Wnt target cyclin D1 and c-Myc to establish if the pathway is constitutively activated in breast cancers arising in Saudi women.

Results: Cytoplasmic β-catenin, indicative of activation of the pathway, was observed in 24% of cases. Expression of APC and Axin, which are components of β-catenin destruction complex, was lost in 5% and 10% of tumors, respectively. Additionally, Wnt signaling inhibitors DKK3, FRP2, and Wnt inhibitory factor 1 (WIF1) were not expressed in 8%, 14%, and 5% breast tumors, respectively. Overall, accumulation of cytoplasmic β-catenin and downregulation of other Wnt pathway proteins (APC/Axin/DKK3/FRP2/WIF1) were found in approximately half of the breast cancers (47%) in our cohort. Consistent with this, analysis of Wnt target genes demonstrated moderate-to-strong expression of c-Myc in 58% and cyclin D1 in 50% of breast cancers. Deregulation of Wnt pathway was not associated with age of onset of the disease, tumor grade, and triple-negative status of breast cancers.

Conclusions: High level of deregulated expression of Wnt pathway proteins suggests its important role in pathogenesis of breast cancers arising in Saudi women who may benefit from development of therapeutic drugs targeting this pathway.

Citing Articles

Epigenetic Regulation in Breast Cancer: Insights on Epidrugs.

Kim A, Mo K, Kwon H, Choe S, Park M, Kwak W Epigenomes. 2023; 7(1).

PMID: 36810560 PMC: 9953240. DOI: 10.3390/epigenomes7010006.


Apogossypolone Inhibits Cell Proliferation and Epithelial-Mesenchymal Transition in Cervical Cancer Activating DKK3.

Li Y, Qu J, Liu L, Sun Y, Zhang J, Han S Front Oncol. 2022; 12:948023.

PMID: 35924156 PMC: 9341244. DOI: 10.3389/fonc.2022.948023.


The β-catenin/CBP signaling axis participates in sepsis-induced inflammatory lung injury.

Cheng X, Liu D, Ren X, Nie Y, Zhao Y, Chen R Exp Biol Med (Maywood). 2022; 247(17):1548-1557.

PMID: 35665630 PMC: 9554161. DOI: 10.1177/15353702221097316.


The Prognostic Value of the Developmental Gene FZD6 in Young Saudi Breast Cancer Patients: A Biomarkers Discovery and Cancer Inducers OncoScreen Approach.

Assidi M, Buhmeida A, Al-Zahrani M, Al-Maghrabi J, Rasool M, Naseer M Front Mol Biosci. 2022; 9:783735.

PMID: 35237656 PMC: 8883113. DOI: 10.3389/fmolb.2022.783735.


Determination of β-catenin Expression in Breast Cancer and Its Relationship with Clinicopathologic Parameters.

Sefidbakht S, Saeedipour H, Saffar H, Mirzaian E Asian Pac J Cancer Prev. 2021; 22(11):3493-3498.

PMID: 34837904 PMC: 9068189. DOI: 10.31557/APJCP.2021.22.11.3493.


References
1.
Damalas A, Kahan S, Shtutman M, Ben-Zeev A, Oren M . Deregulated beta-catenin induces a p53- and ARF-dependent growth arrest and cooperates with Ras in transformation. EMBO J. 2001; 20(17):4912-22. PMC: 125598. DOI: 10.1093/emboj/20.17.4912. View

2.
Nusse R, Varmus H . Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome. Cell. 1982; 31(1):99-109. DOI: 10.1016/0092-8674(82)90409-3. View

3.
Hill V, Ricketts C, Bieche I, Vacher S, Gentle D, Lewis C . Genome-wide DNA methylation profiling of CpG islands in breast cancer identifies novel genes associated with tumorigenicity. Cancer Res. 2011; 71(8):2988-99. DOI: 10.1158/0008-5472.CAN-10-4026. View

4.
Li S, Li S, Sun Y, Li L . The expression of β-catenin in different subtypes of breast cancer and its clinical significance. Tumour Biol. 2014; 35(8):7693-8. DOI: 10.1007/s13277-014-1975-0. View

5.
Salahshor S, Woodgett J . The links between axin and carcinogenesis. J Clin Pathol. 2005; 58(3):225-36. PMC: 1770611. DOI: 10.1136/jcp.2003.009506. View